Genome Stability News Today

Do bats hold the secret to health and longevity? A team led by Professor Emma Teeling, Full Professor of Zoology at University College Dublin (UCD), has won a prestigious European Research Council (ERC) Synergy grant of almost €12 million, to explore this fascinating question.

Femtech developer Aspira Women's Health signs with Dana Farber to license a biomarker-based ovarian cancer diagnostic, a Madrona Venture Labs spin-out adds GPT-enabled virtual agents to billing automation and Dave, an LLM oncology tool, is born.

Whether radiation exposure of fathers can have consequences on their children is one of the most long-standing questions in radiation biology.

Whether radiation exposure of fathers can have consequences on their children is one of the most long-standing questions in radiation biology.

Landmark 5-year follow-up of PAOLA-1 Phase III trial demonstrated LYNPARZA plus bevacizumab meaningfully extended survival with 65.5% of HRD-positive patients surviving 5 years vs. 48.4% treated with

Investegate announcements from AstraZeneca PLC, Lynparza recommended in EU for early breast cancer

Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer. First PARP inhibitor to...

Press release content from Business Wire. The AP news staff was not involved in its creation.

First PARP inhibitor to demonstrate overall survival benefit in early breast cancer ... | March 16, 2022

Investegate announcements from AstraZeneca PLC, Lynparza approved in US for early breast cancer